Immunostimulatory effects of Heyndrickxia coagulans SANK70258
Bioscience, Biotechnology, and Biochemistry · 2025
DOI: 10.1093/bbb/zbae203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2025. Verfasst von Yuki Ikeda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science and Technology, Tokyo University of Science, Tokyo, Japan. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Eubacteriales. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS, Tojuro Iijima Foundation for Food Science and Technology, Mishima Kaiun Memorial Foundation.
Abstract (Originalsprache)
Here, we examined the immunomodulating effects of Heyndrickxia coagulans SANK70258 (SANK70258). Mouse splenocytes treated with γ-ray-irradiated SANK70258 produced higher levels of interferon (IFN)-γ than those with 7 types of lactic acid bacteria. IFN-γ was mainly produced by natural killer (NK) cells, involving IL-12/IL-23, dendritic cells (DCs), and NF-κB signaling. SANK70258 induced the release of IL-6, IL-10, and IL-12p40 from mouse DCs and the expression of cytokine genes in the human monocyte. Cytokine release from SANK70258-treated DCs was partially reduced by the knockdown of Tlr2 or Nod2, and was abolished by Myd88 knockout. DC-stimulating components of SANK70258 were enriched in ether- and butanol-insoluble peptidoglycan-related fractions. The SANK70258 component induced high levels of immunoglobulin (Ig) A production in Peyer’s patch cells, and its oral intake significantly increased intestinal IgA and IgA-expressing B cells in Peyer’s patches in mice. We conclude that the SANK70258 component exhibits high activity as an immunostimulant that induces the production of IFN-γ and IgA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science and Technology, Tokyo University of Science, Tokyo, Japan.
- Science & Innovation Center, Mitsubishi Chemical Corporation, Yokohama, Japan.
ORCID-Profile: Chiharu Nishiyama
Förderung
- JSPS
- Tojuro Iijima Foundation for Food Science and Technology
- Mishima Kaiun Memorial Foundation
- Takeda Science Foundation
Zitieren
APA
Ikeda, Y., Yamashita, N., Ito, N., Minamikawa, N., Okamura, H., Yashiro, T., Hachisu, M., Aida, M., Yamada, R., Nagata, K., & Nishiyama, C. (2025). Immunostimulatory effects of Heyndrickxia coagulans SANK70258. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae203
Vancouver
Ikeda Y, Yamashita N, Ito N, Minamikawa N, Okamura H, Yashiro T, et al. Immunostimulatory effects of Heyndrickxia coagulans SANK70258. Bioscience, Biotechnology, and Biochemistry. 2025. doi:10.1093/bbb/zbae203
BibTeX
@article{Ikeda2025,
author = {Ikeda, Yuki and Yamashita, Niya and Ito, Naoto and Minamikawa, Natsuki and Okamura, Hotaka and Yashiro, Takuya and Hachisu, Masakazu and Aida, Masanori and Yamada, Ryouichi and Nagata, Kazuki and Nishiyama, Chiharu},
title = {Immunostimulatory effects of Heyndrickxia coagulans SANK70258},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2025},
doi = {10.1093/bbb/zbae203}
}
EUVIMED